- Home
- SNY vs SLMBP Comparison
SNY vs SLMBP Comparison
Compare SNY & SLMBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- SLMBP
- Stock Information
- Founded
- SNY 1994
- SLMBP N/A
- Country
- SNY France
- SLMBP United States
- Employees
- SNY N/A
- SLMBP 1710
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- SLMBP Finance: Consumer Services
- Sector
- SNY Health Care
- SLMBP Finance
- Exchange
- SNY Nasdaq
- SLMBP Nasdaq
- Market Cap
- SNY 123.6B
- SLMBP N/A
- IPO Year
- SNY N/A
- SLMBP N/A
- Fundamental
- Price
- SNY $52.76
- SLMBP $74.58
- Analyst Decision
- SNY Buy
- SLMBP
- Analyst Count
- SNY 2
- SLMBP 0
- Target Price
- SNY $62.50
- SLMBP N/A
- AVG Volume (30 Days)
- SNY 3.6M
- SLMBP N/A
- Earning Date
- SNY 04-24-2025
- SLMBP N/A
- Dividend Yield
- SNY 3.05%
- SLMBP N/A
- EPS Growth
- SNY 39.56
- SLMBP N/A
- EPS
- SNY 5.45
- SLMBP N/A
- Revenue
- SNY $48,817,552,946.00
- SLMBP N/A
- Revenue This Year
- SNY $5.35
- SLMBP N/A
- Revenue Next Year
- SNY $6.69
- SLMBP N/A
- P/E Ratio
- SNY $9.68
- SLMBP N/A
- Revenue Growth
- SNY N/A
- SLMBP N/A
- 52 Week Low
- SNY $45.80
- SLMBP N/A
- 52 Week High
- SNY $60.12
- SLMBP N/A
- Technical
- Relative Strength Index (RSI)
- SNY 49.08
- SLMBP 60.54
- Support Level
- SNY $52.23
- SLMBP $69.29
- Resistance Level
- SNY $53.70
- SLMBP $73.97
- Average True Range (ATR)
- SNY 1.34
- SLMBP 1.22
- MACD
- SNY 0.32
- SLMBP 0.62
- Stochastic Oscillator
- SNY 84.33
- SLMBP 100.00
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About SLMBP SLM Corporation Floating Rate Non-Cumulative Preferred Stock Series B
SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.